GSK3B and breast carcinoma: In our study, we demonstrated that GSK3β non-phosphorylatable mutant EZH2 (EZH22A, EZH2S363A, EZH2T367A) enhances cell migration and anchorage-independent growth in breast cancer and mammary epithelial cells.